Kevin Ferreira

Title: Kevin Ferreira: Innovator in Bacterial Targeting Agents

Introduction

Kevin Ferreira is a notable inventor based in Braunschweig, Germany. He has made significant contributions to the field of pharmaceutical compositions, particularly in the development of agents that target bacteria. His innovative work has the potential to enhance diagnostic methods and therapeutic applications.

Latest Patents

Kevin Ferreira holds a patent for "1,4,7,10-tetrazacyclododecane based agents to target bacteria and its use." This invention relates to new compounds that include a siderophore moiety and a core structure capable of chelating metal ions. The compounds may also feature a functional element, such as a marker molecule or a bioactive agent, which can monitor the expression or activity of proteins involved in bacterial infections. Furthermore, the invention encompasses a pharmaceutical composition that can serve as an antibiotic and is applicable in various diagnostic methods, including SPEC, PET, or MRI. Notably, the compound can be part of a theranostic composition, providing both therapeutic and diagnostic benefits.

Career Highlights

Throughout his career, Kevin Ferreira has worked with esteemed organizations, including Helmholtz-Zentrum für Infektionsforschung GmbH. His experience in these research institutions has allowed him to develop groundbreaking innovations in the field of infectious diseases.

Collaborations

Kevin has collaborated with notable colleagues such as Mark Broenstrup and Haiyu Hu. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Kevin Ferreira is a distinguished inventor whose work in bacterial targeting agents showcases his commitment to advancing medical science. His innovative patent and collaborations highlight his significant contributions to the field of pharmaceuticals.